HealthCor Management’s Eli Lilly LLY Stock Holding History

HealthCor Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-103,150	Closed	-$33.4M	–	46
2022 Q3	$33.4M	Buy	103,150 +32,520	+46%	+$10.3M	4.17%	5
2022 Q2	$22.9M	Buy	+70,630	New	+$21.2M	2.3%	16
2017 Q3	–	Sell	-327,064	Closed	-$26.9M	–	46
2017 Q2	$26.9M	Buy	+327,064	New	+$26.7M	0.97%	29
2016 Q4	–	Sell	-825,000	Closed	-$66.2M	–	47
2016 Q3	$66.2M	Buy	+825,000	New	+$66M	4.03%	10
2016 Q1	–	Sell	-1,325,000	Closed	-$112M	–	46
2015 Q4	$112M	Buy	1,325,000 +325,000	+33%	+$27M	6.78%	2
2015 Q3	$83.7M	Buy	+1,000,000	New	+$84.4M	4.71%	7
2013 Q4	–	Sell	-121,929	Closed	-$6.14M	–	61
2013 Q3	$6.14M	Buy	+121,929	New	+$6.38M	0.33%	51

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HealthCor Management's LLY Position: Q4 2022 in Review

HealthCor Management sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 103,150 shares — an estimated $33.4M sold.

HealthCor Management first reported a position in LLY in Q3 2013 and held it in 7 quarters. The position peaked at $112M in Q4 2015. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

HealthCor Management reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
HealthCor Management sold 103,150 Eli Lilly shares in Q4 2022, an estimated $33.4M.
HealthCor Management first reported a position in Eli Lilly in Q3 2013 and held it in 7 quarters.
HealthCor Management's Eli Lilly position peaked at $112M in Q4 2015.
2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.